ID: hyp-SDA-2026-04-09-gap-debate-20260409-2
Hypothesis
Glycan-Disrupting Tau Disaggregation
Enzymatic removal of specific glycan modifications from tau vesicle surfaces using targeted glycosidases could disrupt the molecular interactions that promote tau aggregation, effectively 'dissolving' the pathological protein networks by.
EvidencePending (0%)📖 3 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
Enzymatic removal of specific glycan modifications from tau vesicle surfaces using targeted glycosidases could disrupt the molecular interactions that promote tau aggregation, effectively 'dissolving' the pathological protein networks by altering their surface chemistry.
🧬 Mechanism
🔗 Mechanism from KG for NEU1
Auto-built from this analysis's top knowledge-graph edges.
graph TD
HK1["HK1"] -->|participates in| glucose_metabolism["glucose_metabolism"]
ST6GAL1["ST6GAL1"] -->|regulates| sialylation["sialylation"]
MAPT["MAPT"] -->|participates in| vesicle_transport["vesicle_transport"]
ST6GAL1_1["ST6GAL1"] -->|catalyzes| sialylation_2["sialylation"]
LGALS3["LGALS3"] -->|regulates| autophagy["autophagy"]
MGAT5["MGAT5"] -->|catalyzes| N_glycosylation["N_glycosylation"]
glycan_patterns["glycan_patterns"] -->|characterizes| tau_vesicles["tau_vesicles"]
n2_deoxy_D_glucose_analogs["2-deoxy-D-glucose analogs"] -->|disrupts| glycosylation_patterns["glycosylation patterns"]
LGALS3_3["LGALS3"] -->|targets| tau_vesicles_4["tau_vesicles"]
MGAT5_5["MGAT5"] -->|marks| tau_vesicles_6["tau_vesicles"]
NEU1["NEU1"] -.->|inhibits| tau_aggregation["tau_aggregation"]
synthetic_glycan_mimetics["synthetic_glycan_mimetics"] -.->|inhibits| tau_spreading["tau_spreading"]
style HK1 fill:#ce93d8,stroke:#333,color:#000
style glucose_metabolism fill:#81c784,stroke:#333,color:#000
style ST6GAL1 fill:#ce93d8,stroke:#333,color:#000
style sialylation fill:#ffd54f,stroke:#333,color:#000
style MAPT fill:#ce93d8,stroke:#333,color:#000
style vesicle_transport fill:#4fc3f7,stroke:#333,color:#000
style ST6GAL1_1 fill:#ce93d8,stroke:#333,color:#000
style sialylation_2 fill:#4fc3f7,stroke:#333,color:#000
style LGALS3 fill:#ce93d8,stroke:#333,color:#000
style autophagy fill:#4fc3f7,stroke:#333,color:#000
style MGAT5 fill:#ce93d8,stroke:#333,color:#000
style N_glycosylation fill:#4fc3f7,stroke:#333,color:#000
style glycan_patterns fill:#4fc3f7,stroke:#333,color:#000
style tau_vesicles fill:#4fc3f7,stroke:#333,color:#000
style n2_deoxy_D_glucose_analogs fill:#4fc3f7,stroke:#333,color:#000
style glycosylation_patterns fill:#4fc3f7,stroke:#333,color:#000
style LGALS3_3 fill:#4fc3f7,stroke:#333,color:#000
style tau_vesicles_4 fill:#4fc3f7,stroke:#333,color:#000
style MGAT5_5 fill:#ce93d8,stroke:#333,color:#000
style tau_vesicles_6 fill:#4fc3f7,stroke:#333,color:#000
style NEU1 fill:#ce93d8,stroke:#333,color:#000
style tau_aggregation fill:#4fc3f7,stroke:#333,color:#000
style synthetic_glycan_mimetics fill:#4fc3f7,stroke:#333,color:#000
style tau_spreading fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Supports
Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System.
Supports
Ganglioside sialylation modulates tau internalization and pathology spread.
Supports
NEU1-Mediated Extracellular Vesicle Glycosylation in Alzheimer's Disease: Mechanistic Insights into Intercellular Communication and Therapeutic Targeting.
Contradicts
NEU1-A Unique Therapeutic Target for Alzheimer's Disease.
Contradicts
NEU1-Mediated Extracellular Vesicle Glycosylation in Alzheimer's Disease: Mechanistic Insights into Intercellular Communication and Therapeutic Targeting.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NEU1
No curated PDB or AlphaFold mapping for NEU1 yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NEU1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0535
Events (7d)
0
Price History
▲6.0%💾 Resource Usage
LLM Tokens
14,284
$0.0857
Total Cost
$0.0857
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF NEU1 is overexpressed (≥3-fold endogenous levels) in human neuroblastoma cells inducibly expressing tau, THEN extracellular tau concentration in conditioned media at 72 hours will decrease by at le | Extracellular tau ELISA signal reduced to ≤60% of vector control levels, with corresponding increase in intracellulartau showing impaired secretion | — no observation — | pending | 0.30 |
| IF recombinant tau protein is pre-treated with neuraminidase (to remove terminal sialic acid residues) PRIOR to aggregation induction, THEN Thioflavin-S fluorescence signal at 48 hours will be reduced | Thioflavin-S fluorescence signal ≤70% of vehicle-treated tau aggregation controls | — no observation — | pending | 0.35 |
🔮 Falsifiable Predictions (2)
pendingconf 35%
IF recombinant tau protein is pre-treated with neuraminidase (to remove terminal sialic acid residues) PRIOR to aggregation induction, THEN Thioflavin-S fluorescence signal at 48 hours will be reduced by at least 30% compared to untreated tau controls.
Predicted outcome: Thioflavin-S fluorescence signal ≤70% of vehicle-treated tau aggregation controls
Falsification: No reduction (≥95% of control) or increase in Thioflavin-S signal in neuraminidase-treated tau samples at 48 hours, indicating sialic acid removal does not inhibit tau aggregation
pendingconf 30%
IF NEU1 is overexpressed (≥3-fold endogenous levels) in human neuroblastoma cells inducibly expressing tau, THEN extracellular tau concentration in conditioned media at 72 hours will decrease by at least 40% compared to vector-transfected cells.
Predicted outcome: Extracellular tau ELISA signal reduced to ≤60% of vector control levels, with corresponding increase in intracellulartau showing impaired secretion
Falsification: Extracellular tau levels unchanged or increased (≥95% of vector control) at 72 hours, indicating NEU1 activity does not modulate tau secretion
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.